- Review the interactive media piece assigned by your Instructor.
- Reflect on the patient’s symptoms and aspects of the disorder presented in the interactive media piece.
- Consider how you might assess and treat patients presenting with the symptoms of the patient case study you were assigned.
- You will be asked to make three decisions concerning the diagnosis and treatment for this patient. Reflect on potential co-morbid physical as well as patient factors that might impact the patient’s diagnosis and treatment.
By Day 7 of Week 8
Write a 1- to 2-page summary paper that addresses the following:
- Briefly summarize the patient case study you were assigned, including each of the three decisions you took for the patient presented.
- Based on the decisions you recommended for the patient case study, explain whether you believe the decisions provided were supported by the evidence-based literature. Be specific and provide examples. Be sure to support your response with evidence and references from outside resources.
- What were you hoping to achieve with the decisions you recommended for the patient case study you were assigned? Support your response with evidence and references from outside resources.
- Explain any difference between what you expected to achieve with each of the decisions and the results of the decision in the exercise. Describe whether they were different. Be specific and provide examples.
You will submit this Assignment in Week 8.
Major Neurocognitive Disorder
The case scenario assigned is that of Mr. Akkad, a 76-year-old Iranian male brought to the hospital by his son, who complains that his father has been showing “strange behavior” over the past two years. The client has lost interest in religious activities and has become critical to everyone. The things he used to take seriously has now become amusement or ridicule. The client has also become forgetful and it has become challenging to find the right words during communication from the mental examination, the client has been diagnosed with major neurocognitive disorder. In light of this, this paper seeks to provide the three decisions taken in regard to the treatment of the above client.
Decision 1: Begin Aricept (donepezil) 5 mg orally at BEDTIME
Aricept is a cholinesterase inhibitor and has been approved for use in all stages of dementia. The rationale for selecting this drug is given that the patient needs to take it once daily. It has also been shown to work better in improving the symptoms compared to Exelon, and Razadyne which have severe side effects (Tricco et al., 2017). In addition, Aricepts is cheaper compared to Exelon and Razadyne making it the most suitable option. With the above decision, I was hoping for an improvement in the symptoms such as a slight increase in interest in the actives that the client used to enjoy. However, the expected results were different from the actual outcomes, which showed that the outcome of the patients.Click link below to purchase full tutorial at $10